COVID-19: A Message from Our CEO
"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL LimitedRead Our Letter to Patients
Explainer: What Is PhRMA?
CSL CEO Paul Perreault recently joined the board of the Pharmaceutical Research and Manufacturers of America.
Employees Receive COVID-19 Vaccine in Illinois
Kankakee County Health Department identifies CSL Behring as a frontline essential workplace and provides on-site vaccination.…
Lighting the Night for Rare Disease Day
Landmarks around the world were illuminated on Sunday in honor of rare disease patients.
Take the Rare Disease Day Quiz
Test your knowledge about rare diseases, which affect more people than you think.
Learn, Interact and Celebrate
Rare Disease Day 2021 is happening amid a global pandemic. Here are three safe ways to take part.
Standing Up for Rare Disease Patients in Europe
“Donating plasma saves lives,” says CSL Behring’s General Manager for Commercial Operations in Europe.
"Why I Donate Plasma"
CSL employees share how helping patients is simply a matter of rolling up their sleeves.
CSL CEO Paul Perreault on Rare Disease Day
See the video Perreault shared with employees: “Reflect on the work we do and the people who count on us to keep innovating.”